Finance

Beta
Lists
002365:SHE
Qianjiang Yongan Pharmaceutical Co Ltd
CNÂ¥11.01
+1.29%
(+0.14) 1D
Jun 16, 3:04:36 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002365...
Open
CNÂ¥10.79
High
CNÂ¥11.02
Low
CNÂ¥10.68
Mkt. cap
3.20B
Avg. vol.
7.54M
Volume
7.43M
Dividend
0.91%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 11, 2026
P/E ratio
92.05
52-wk high
CNÂ¥32.14
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.12
Shares outstanding
294.68M
No. of employees
912
Open
CNÂ¥10.79
High
CNÂ¥11.02
Low
CNÂ¥10.68
Mkt. cap
3.20B
Avg. vol.
7.54M
Volume
7.43M
Dividend
0.91%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 11, 2026
P/E ratio
92.05
52-wk high
CNÂ¥32.14
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.12
Shares outstanding
294.68M
No. of employees
912
News stories
From sources across the web
About Qianjiang Yongan Pharmaceutical Co Ltd
CEO-
Employees912
FoundedJun 18, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
196.22M
209.77M
206.02M
235.90M
Cost of goods sold
155.20M
169.02M
173.34M
188.18M
Cost of revenue
155.20M
169.02M
173.34M
188.18M
Research and development expenses
8.94M
8.72M
4.79M
8.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.55M
32.66M
22.80M
23.64M
Operating expense
34.84M
44.57M
30.70M
34.69M
Total operating expenses
190.04M
213.59M
204.04M
222.87M
Operating income
6.18M
-3.82M
1.98M
13.03M
Other non operating income
-1.36M
1.12M
-1.92M
-5.57M
EBT including unusual items
17.27M
8.54M
-8.14M
9.16M
EBT excluding unusual items
12.82M
9.56M
5.39M
12.70M
Income tax expense
2.02M
753.52K
1.01M
1.17M
Effective tax rate
11.71%
8.82%
-12.40%
12.78%
Other operating expenses
2.18M
2.44M
2.38M
2.44M
Net income
16.86M
13.00M
-3.00M
7.74M
Net profit margin
8.59%
6.20%
-1.46%
3.28%
Earnings per share
-
-
-
-
Interest and investment income
6.63M
14.15M
5.67M
5.24M
Interest expense
-294.85K
-217.73K
-203.05K
-
Net interest expenses
6.33M
13.93M
5.47M
5.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
34.65M
24.35M
31.15M
42.20M
Gain or loss from assets sale
-32.63K
32.63K
-185.68K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more